Morrison L M, Emanuelsson B M, McClure J H, Pollok A J, McKeown D W, Brockway M, Jozwiak H, Wildsmith J A
Department of Anaesthetics, Royal Infirmary of Edinburgh.
Br J Anaesth. 1994 Feb;72(2):164-9. doi: 10.1093/bja/72.2.164.
Ninety-one patients were allocated randomly to three groups to receive 1% ropivacaine 10 ml, 0.5% ropivacaine 20 ml or 0.5% bupivacaine 20 ml extradurally. Intermittent sensory (pinprick) and motor (Bromage scale) assessments of the block produced were recorded, with an assessment of the quality of the block and the requirement for supplementary analgesia. There was little difference between the groups in frequency, onset, duration or spread of sensory block. However, the motor block produced by 0.5% ropivacaine was less intense and of shorter duration than that with bupivacaine. The block produced by the smaller volume of ropivacaine was less reliable clinically than the larger, more dilute, solution and more anaesthetic supplements were required in that group. Cardiovascular changes were similar in all three groups. The peak plasma concentration of ropivacaine was significantly greater and T1/2 significantly shorter than those of bupivacaine, although no patient showed any features of systemic toxicity. The systemic kinetics of ropivacaine were not influenced significantly by varying the concentration or volume administered.
91例患者被随机分为三组,分别硬膜外给予1%罗哌卡因10毫升、0.5%罗哌卡因20毫升或0.5%布比卡因20毫升。记录所产生阻滞的间歇性感觉(针刺)和运动( Bromage评分)评估结果,同时评估阻滞质量和补充镇痛的需求。三组在感觉阻滞的频率、起效时间、持续时间或范围方面差异不大。然而,0.5%罗哌卡因产生的运动阻滞比布比卡因轻且持续时间短。较小剂量罗哌卡因产生的阻滞在临床上不如较大剂量、更稀释溶液可靠,该组需要更多的麻醉补充剂。三组的心血管变化相似。罗哌卡因的血浆峰浓度显著高于布比卡因,T1/2显著短于布比卡因,尽管没有患者出现任何全身毒性特征。罗哌卡因的全身动力学不受给药浓度或剂量变化的显著影响。